Insmed | INSM - Umsatzerlöse





Der Umsatz Veränderung Datum
BioMarin Pharmaceutical USD 990M 224M 2026-06
Cytokinetics USD 28.6M 9.25M 2026-06
DBV Technologies USD 645K 2.13M 2025-12
Gilead Sciences USD 7.8B 800M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 425.49M 119.53M 2026-06
Novartis USD 13.11B 750M 2026-03
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06